Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Acetaminophen × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Carcinoma in Situ 2 Agnosia 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Pain, Postoperative 1 Pain 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

pembrolizumab 36 Cyclophosphamide 21 Bevacizumab 16 Standard of Care 12 Nivolumab 12 Carboplatin 12 Blood Specimen Collection 12 atezolizumab 11 Paclitaxel 10 Doxorubicin 10 Rituximab 9 Pemetrexed 9 Interviews as Topic 9 Fluorouracil 9 fludarabine 8 Prednisone 8 Dexamethasone 8 Surveys and Questionnaires 7 Radiotherapy 7 Oxaliplatin 7 Leucovorin 7 venetoclax 6 olaparib 6 durvalumab 6 Letrozole 6 Fulvestrant 6 Exercise 6 Biopsy 6 pertuzumab 5 palbociclib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05051735 2026-02-25

PARASTOP

Oslo University Hospital

Phase 3 Completed

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡